Not Yet Recruiting OBSERVATIONAL NCT07156617
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
Sponsor: Xuhua Duan
Conditions
Hepatocellular Carcinoma (HCC)
Interventions
Interventional therapy Systemic therapy
Updated 1 time since 2025 Last updated: Aug 28, 2025 Started: Oct 1, 2025 Primary completion: Oct 1, 2027 Completion: Oct 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Hepatocellular Carcinoma (HCC) and is currently actively recruiting participants. Xuhua Duan leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Not Yet Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Xuhua Duan
Data source: The First Affiliated Hospital of Zhengzhou University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Dengzhou, China , Haikou, China , Jiaozuo, China , Kaifeng, China , Luoyang, China , Nanchang, China , Shangqiu, China , Wuxi, China , Xingtai, China , Zhengzhou, China and 1 more location